IL37 and neoplasm: Interleukin-23 has been involved in immunity against tumors (29, 47) and acute infections (30, 31) but also contributes to tumor promotion and growth (40, 48) and the development of autoimmune diseases, mainly through the induction of a Th17 response (30, 49).